Invivyd, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNew Haven, CT
SAM.gov UEIKNFJE2EJLH87
Invivyd develops monoclonal antibody medicines for serious infectious diseases, with a focus on viral threats including COVID-19. The company uses a proprietary integrated technology platform to create, assess, and monitor antibody candidates for prevention or treatment applications. Invivyd has received Emergency Use Authorization (EUA) for PEMGARDA®.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Invivyd, INC. | New Haven | CT | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.